Ceribell
Ceribell (CBLL) is a publicly traded Non-Invasive Clinical EEG company founded in 2014 and based in Sunnyvale, United States.
Offers a rapid-deployment EEG system with AI-powered seizure detection for emergency and ICU settings. Raised $145M Series C in 2023. Ceribell System is FDA-cleared and deployed in hundreds of hospitals. Focused on reducing time to seizure diagnosis.
Bringing non-invasive EEG into acute-care workflows with machine learning, demonstrating how brain sensing can scale beyond research into high-stakes clinical decision-making.
ceribell.com ↗·Non-Invasive Clinical EEG·
United States·public · CBLL 
